Rexgene Biotech Co., Ltd. - Net Worth and Insider Trading

Rexgene Biotech Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rexgene Biotech Co., Ltd. owns 2 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , and Ocuphire Pharma Inc (OCUP) .

Click here to see the complete history of Rexgene Biotech Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Rexgene Biotech Co., Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
REXN	Rexahn Pharmaceuticals Inc	2007-12-24	10 percent owner
OCUP	Ocuphire Pharma Inc	2005-05-13	10 percent owner

Rexgene Biotech Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rexgene Biotech Co., Ltd. Ownership Network

Ownership Network List of Rexgene Biotech Co., Ltd.

No Data

Ownership Network Relation of Rexgene Biotech Co., Ltd.

Rexgene Biotech Co., Ltd. Owned Company Details

What does Rexahn Pharmaceuticals Inc do?

Who are the key executives at Rexahn Pharmaceuticals Inc?

Rexgene Biotech Co., Ltd. is the 10 percent owner of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .

Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rexahn Pharmaceuticals Inc Insider Transactions

No Available Data

Rexgene Biotech Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Rexgene Biotech Co., Ltd.. You might contact Rexgene Biotech Co., Ltd. via mailing address: 401 Wooyoung Venture Bldg., Seocho-dong Seocho-gu, Seoul M5 1330-13.

Discussions on Rexgene Biotech Co., Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.